(NASDAQ: LIN) Linde's forecast annual revenue growth rate of 3.89% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.6%.
Linde's revenue in 2025 is $33,005,000,000.On average, 5 Wall Street analysts forecast LIN's revenue for 2025 to be $16,038,687,808,975, with the lowest LIN revenue forecast at $15,583,700,960,032, and the highest LIN revenue forecast at $16,444,082,781,096. On average, 5 Wall Street analysts forecast LIN's revenue for 2026 to be $16,865,724,631,854, with the lowest LIN revenue forecast at $16,505,144,656,301, and the highest LIN revenue forecast at $17,292,486,223,788.
In 2027, LIN is forecast to generate $17,637,405,258,200 in revenue, with the lowest revenue forecast at $17,321,191,013,177 and the highest revenue forecast at $18,259,117,570,980.